Our pick · Oct 2026
Embody
from $69/mo
Compounded semaglutide · 12-month plan · $828 up front · checked Oct 16
- LegitScript certified
- State-licensed prescribers
Our pick is a commercial choice. We may earn a commission when you join.
Does Indiana Medicaid cover GLP-1s for weight loss?
If you are an adult and weight loss is your only reason, Indiana Medicaid does not cover a GLP-1.
If one of the uses below applies to you, your prescriber can ask Indiana Medicaid to cover that drug. Read the rule and its criteria.
Which drugs Indiana Medicaid covers, and for what:
We checked 2 official documents on October 15, 2026. This is information, not medical advice or a benefit decision.
16 programs that serve Indiana publish a complete monthly price, from $69 at Embody to $299 at Willow.
Our pick · Oct 2026
from $69/mo
Compounded semaglutide · 12-month plan · $828 up front · checked Oct 16
Our pick is a commercial choice. We may earn a commission when you join.
Some programs are affiliate partners, and we may earn a commission if you join through our link. Payment never moves a row. How we rank
Compounded semaglutide · 12-mo prepay
$828 up front
Advertised program price, not an insurance copay.
Good: 7.6/10 · Compounded
Checked Oct 16, 2026; a rating claim didn't match Trustpilot.
Embody's $69 is not a flat price at checkout. Its public catalogue charges $79/$129 for one month, or $69/$119 a month when you prepay twelve months ($828/$1,428). A separate promotion advertises $69/$119 flat monthly, and its terms dated April 24 still list other introductory and fixed-price programs. Embody doesn't say which of these sets your first charge and renewal, so ask before you pay. Sources checked October 16, 2026. Consultation: included. Shipping: free. Payments are normally non-refundable. If Embody's provider determines medical disqualification, its refund policy allows a refund for unused services after deducting services already provided. Cancellation otherwise stops future renewal. The twelve-month semaglutide plan commits $828 up front; cancellation requests must reach support at least 72 hours before the next billing date.
We checked this price on Oct 16, 2026.
Full review and sourcesCompounded semaglutide · billed monthly
Ask about membership
Advertised program price, not an insurance copay.
Good: 7.8/10 · Both
Checked Oct 16, 2026.
all-inclusive month-to-month semaglutide, flat at every dose (tirzepatide $129/mo); Compounded Semaglutide (month-to-month): Advertised monthly plan, same price across doses. No annual prepayment. Confirm the full renewal bill and applicable membership terms. Consultation: included. Shipping: free. The compounded offer says no separate membership fee, while Eden's general terms also describe a membership with medication billed separately. Confirm which terms apply to your selected offer and the full renewal bill; checkout has not been independently verified.
We checked this price on Aug 28, 2026.
Full review and sources12-mo prepay
$1,188 up front
Advertised program price, not an insurance copay.
Fair: 7.3/10 · Compounded
Checked Jul 18, 2026; few independent reviews yet.
$1,188 upfront for 12 months; applicable taxes may add to the bill 12-month semaglutide rate, $1,188 paid up front. A separate Subscribe and Save offer is $149 for the first month, then $165; the pricing table also lists a $190 first-month option Compounded Semaglutide, 12-Month Plan: $1,188 billed up front for 12 months, $99/mo, renewing at $1,163 on its pricing page. The FAQ directs cancellation by email; unshipped-dose refunds remain subject to processing and dispensing conditions. Consultation: included. Shipping: included (free overnight shipping). The dispensing 503A pharmacy is described by type while its name and license remain absent from the public site
We checked this price on Sep 3, 2026.
Full review and sourcesCompounded semaglutide · 12-mo prepay
$1,188 up front
Advertised program price, not an insurance copay.
Good: 7.1/10 · Compounded
Checked Oct 16, 2026; a rating claim didn't match Trustpilot.
Annual semaglutide: $1,188 upfront. Shortest plan: $149 every 4 weeks, not a calendar month.
12-month compounded semaglutide plan: $1,188 billed every 12 months. The shortest plan is $149 every 4 weeks; plans renew until cancelled
We checked this price on Oct 5, 2026.
Full review and sourcesCompounded semaglutide lozenge · auto-refill
Advertised program price, not an insurance copay.
Fair: 6.2/10 · Compounded
Checked Oct 16, 2026.
as low as, auto-refill
We checked this price on Oct 2, 2026.
Full review and sources$104.50/4 weeks at Luvo Health
First 4 weeks
Then $209/4 weeks
Advertised program price, not an insurance copay.
Limited: 4.2/10 · Both
Checked Sep 26, 2026; some details not published.
Semaglutide injection: $104.50 first 4 weeks, then $209 every 4 weeks. Medication, clinical review, support and shipping included.
Semaglutide injection 4-week starter: $104.50, then $209 every four weeks. Medication, clinician review, support and shipping included. Four weeks is not a calendar month.
We checked this price on Oct 10, 2026.
Full review and sourcesCompounded; not FDA-approved. Prescription required only if a licensed provider finds it appropriate. Our referral opens Luvo’s longevity page. Choose Weight Loss from its menu to view GLP-1 options.
12-mo prepay
$1,308 up front
Advertised program price, not an insurance copay.
Very good: 8.7/10 · Compounded
Checked Oct 18, 2026; some details not published.
$1,308 upfront for 12 months; applicable taxes may add to the bill $109/mo is compounded semaglutide on Belle's 12-month supply, charged in full at checkout ($1,308). Compounded tirzepatide is $179/mo on 12 months ($2,148), $199 on 6, $219 on 2 and $249 for one month, and Belle's offer page sells tirzepatide at $149/mo for 12 months or $179/mo for 6. Every dose costs the same; shipping, supplies and clinician care are included. Checked October 18, 2026.
We checked this price on Oct 18, 2026.
Full review and sourcesFirst 4 weeks
Then $247/4 weeks
Advertised program price, not an insurance copay.
Limited: 4.8/10 · Both
Checked Oct 16, 2026; few independent reviews yet.
Semaglutide injection: $147 first month, then $247 every 28 days. Tirzepatide: $249, then $349. Same price at every dose; consultation and shipping included.
First month: $147 for compounded semaglutide injection, then $247 every 28 days. Compounded tirzepatide injection costs $249 for the first month, then $349 every 28 days. Medication, the initial consultation and shipping are included, and the price is the same at every dose (wellorithm.com/pricing, checked 2026-10-16). Four weeks is not a calendar month, so you pay 13 times a year.
We checked this price on Oct 16, 2026.
Full review and sourcesCompounded semaglutide · 12-mo prepay
$1,900 up front
Advertised program price, not an insurance copay.
Fair: 6/10 · Both
Checked Oct 16, 2026; few independent reviews yet.
12-month compounded semaglutide plan: $1,900 upfront. Month-to-month is $249.
We checked this price on Sep 3, 2026.
Full review and sourcesCompounded semaglutide · 1-mo plan
Advertised program price, not an insurance copay.
Good: 7.2/10 · Both
Checked Oct 16, 2026; a rating claim didn't match Trustpilot.
from $119 on a plan $159/mo buys the one-month semaglutide plan on its pricing page, struck from a $228.60/mo list price. One month of tirzepatide is $249/mo. The lowest advertised prices, $119/mo semaglutide and $179/mo tirzepatide, are 12-month plans billed up front, verified 2026-09-03 Compounded Semaglutide (1-month plan): $159/month with no commitment, total $159, struck from $228.60/mo on its pricing page. This is the real month-to-month entry price (verified 2026-09-03) Compounded Semaglutide Microdose: Same ladder as the full dose against a $199.80/mo list price: $159/month for one month, $149 for three, $129 for six, $119 on the 12-month plan, billed $1,428 up front (verified 2026-10-17 on bmiMD's semaglutide microdose page) Consultation: included (usually same-day telehealth). Shipping: Free. The $119/mo semaglutide headline is a 12-month plan billed $1,428 up front, and once your first order goes to the pharmacy, that payment is non-refundable if you cancel voluntarily; you can take the remaining shipments or convert their value to bmiMD credit. Paying one month at a time costs $159 for semaglutide and $249 for tirzepatide
We checked this price on Sep 3, 2026.
Full review and sourcesConfirm the full bill
Advertised program price, not an insurance copay.
Good: 7.9/10 · Both
Checked Oct 16, 2026; some details not published.
the $159 starting price is the 12-month semaglutide plan on the pricing page; 6-month is $179 and month to month is $199, verified 2026-09-03 Compounded Semaglutide (as low as): 'As low as $159/mo' on the homepage banner, verified 2026-09-03. The pricing page states this rate is the 12-month plan, with $179 on six months. Covered by the 120 day guarantee, which requires first time use of the medication class and four logged member commitments Consultation: included. Shipping: free. Brand name Wegovy, Zepbound and Foundayo sit behind a separate Shed membership, quoted at $125 a month on all three product pages, with the medication billed on top by the dispensing pharmacy. The small print on the Wegovy and Zepbound pages still says $99, so Shed's own pages disagree on the figure.
We checked this price on Sep 3, 2026.
Full review and sourcesBilled monthly
$99/mo on a longer plan
Advertised program price, not an insurance copay.
Fair: 6.7/10 · Compounded
Checked Jul 2, 2026.
month-to-month, from $99 on a plan month-to-month; the annual semaglutide plan is a $99 monthly equivalent with $1,188 prepaid for 12 months and does not auto-renew
We checked this price on Sep 23, 2026.
Full review and sourcesYearly plan
Advertised program price, not an insurance copay.
Good: 7.6/10 · Both
Checked Oct 16, 2026; a rating claim didn't match Trustpilot.
compounded GLP-1 from $179/mo on a yearly subscription, all doses included; Gala also runs a separate $149/mo microdose page on a 3-month plan, and its main site lists 3-month GLP-1 plans from $199/mo, with the final price confirmed at checkout Compounded Semaglutide or Tirzepatide (yearly plan, all doses): From $179/mo on a yearly subscription; the product page lists both molecules and includes all doses Consultation: included. Shipping: free. Brand-name Ozempic here is $1,299/mo, materially above NovoCare's Wegovy pen $199/mo for the first two 0.25 mg or 0.5 mg fills through December 31, 2026, then $349/mo at standard strengths or $399/mo for Wegovy HD; oral pill from $149/mo, dose-dependent. Buy brand-name elsewhere; Gala's value is its compounded GLP-1 line.
We checked this price on Oct 17, 2026.
Full review and sources$212/4 weeks equivalent at Enhance MD
48-week prepay
Advertised program price, not an insurance copay.
Excellent: 9.4/10 · Compounded
Checked Oct 16, 2026; some details not published.
prepaid 48-week plan; confirm the full upfront charge $212 advertised four-week equivalent on the prepaid 48-week plan, not a calendar-year subscription; shortest plan is $249 billed every 4 weeks Compounded Semaglutide (12-month plan): Advertised four-week equivalent; prepaid every 48 weeks, not a calendar year Consultation: included. Shipping: free. The $212 headline is a four-week equivalent on a prepaid 48-week plan, not a calendar-year price. The shortest plan costs $249 every four weeks on the GLP-1 Core pricing page (verified 2026-09-03)
We checked this price on Aug 28, 2026.
Full review and sourcesfrom$297/mo at Direct Meds GLP-1
Confirm the full bill
Advertised program price, not an insurance copay.
Good: 7.5/10 · Compounded
Checked Oct 16, 2026.
Confirm the current prescribed treatment and full bill with the provider.
We checked this price on Sep 3, 2026.
Full review and sourcesConfirm the full bill
Advertised program price, not an insurance copay.
Good: 7.6/10 · Compounded
Checked Oct 16, 2026; a rating claim didn't match Trustpilot.
$299/mo is a starting program price, not one rate for every product. Willow's current help center pricing article lists compounded semaglutide injections at $299/mo up to 3.5 mg and $399/mo at 7 mg, tirzepatide injections at $399/mo through 6.375 mg then $499/mo at 8.5 and 11 mg, $524/mo at 13.5 mg and $549/mo at 17 mg, semaglutide tablets at $299/mo for all listed dosages, and tirzepatide tablets at $399/mo at 6 and 10 mg and $459/mo at 20 mg. Public price schedule checked September 26, 2026; confirm the prescribed product and current quote. Compounded Semaglutide (injectable): Covers medication, consultations, shipping and dose adjustments. $299/mo holds to 3.5 mg, then $399/mo at 7 mg on the help center pricing article, verified 2026-09-03 Compounded Semaglutide (oral tablet, daily): Compounded daily dissolving tablet, $299/mo for all listed dosages in Willow's current help center price schedule. This is distinct from the injection's dose ladder and is not FDA-approved Wegovy. Price checked September 26, 2026. Consultation: included. Shipping: free. The reviewed catalogue lists compounded products; a current brand-name Wegovy or Zepbound offer did not appear there
We checked this price on Sep 26, 2026.
Full review and sources8 more programs serve Indiana without one complete monthly price: AgelessRx, Breeze Meds, Collective, Maximus, Nu Image Medical, Oak Longevity, Ro and Sesame Care. Compare their terms in the price index.
We left out 13 programs whose service-area list has a caveat for Indiana or is incomplete, so confirm your address at intake.
A program that serves Indiana still decides whether to prescribe, and it does not take Medicaid. Most sell compounded semaglutide or tirzepatide, which is not FDA-approved. Check a compounded provider before you pay.
Here is our summary of the Indiana Medicaid rules we checked, with their criteria and limits.
Indiana Medicaid covers Zepbound only for sleep apnea and Wegovy only for heart risk or MASH, not GLP-1 medicines for weight loss alone, under its statewide preferred drug list effective October 1, 2026, which excludes any agent used to promote weight loss. Indiana applies that list to both fee-for-service and managed-care claims, including the Healthy Indiana Plan. Indiana Medicaid prefers Zepbound but approves it only if you are an adult with moderate to severe obstructive sleep apnea, a BMI of 30 or higher and no diabetes. It lists Wegovy injection as non-preferred and can approve it to lower your heart attack and stroke risk (age 45 or older, BMI 27 or higher, a past heart attack, stroke or artery disease, no diabetes) or for MASH, a liver disease, at fibrosis stage F2 or F3. It limits Wegovy tablets to the heart-risk use, and your prescriber must explain why the injection does not suit you. We did not confirm whether a separate under-21 pathway is still in use, so if you are asking for a child, ask the plan directly.
A drug on the preferred list is not covered for every use, so check the rule for yours. A weight-loss exclusion leaves diabetes and other medical requests to their own rules.
We checked Indiana Medicaid statewide uniform preferred drug list, effective for claims from October 1, 2026 (exclusions page 1, GLP-1 class page 39) on October 15, 2026.
We checked Indiana Medicaid PA criteria: GLP-1 receptor agonists and combinations, July 1, 2026 on October 15, 2026.
Call your Medicaid plan, Medicare drug plan or private insurer with these questions, and keep the reference number for each call.
Before you pay cash, confirm:
An “insurance accepted” badge does not tell you your benefit, so ask your plan how its review works.
Your prescriber sends Indiana Medicaid a request with the records that show you meet the rule for your drug and diagnosis, and Indiana Medicaid decides.
What your prescriber usually sends:
Your prescriber works from these Indiana Medicaid documents:
Your prescriber's office files the request; you cannot file it yourself. If Indiana Medicaid says no, ask for the reason in writing, because the notice tells you how to ask for a review and by when.
Medicare's GLP-1 Bridge follows federal rules in every state, so Indiana Medicaid's policy does not decide your Medicare benefit.
We checked CMS's Bridge guidance for Part D plans on September 26, 2026.
Two free official services can help you, and we earn no commission from either.
Indiana Medicaid covers Zepbound only for sleep apnea and Wegovy only for heart risk or MASH, not GLP-1 medicines for weight loss alone, under its statewide preferred drug list effective October 1, 2026, which excludes any agent used to promote weight loss.
Indiana applies that list to both fee-for-service and managed-care claims, including the Healthy Indiana Plan. Indiana Medicaid prefers Zepbound but approves it only if you are an adult with moderate to severe obstructive sleep apnea, a BMI of 30 or higher and no diabetes. It lists Wegovy injection as non-preferred and can approve it to lower your heart attack and stroke risk (age 45 or older, BMI 27 or higher, a past heart attack, stroke or artery disease, no diabetes) or for MASH, a liver disease, at fibrosis stage F2 or F3. It limits Wegovy tablets to the heart-risk use, and your prescriber must explain why the injection does not suit you. We did not confirm whether a separate under-21 pathway is still in use, so if you are asking for a child, ask the plan directly. Before you pay, confirm your exact drug, your diagnosis, any age rules and your plan's authorization steps.
Yes.
Medicare's GLP-1 Bridge follows federal eligibility rules in every state, not Indiana Medicaid's policy. Your ordinary Part D coverage depends on your prescription and your drug plan, and the Bridge runs its own eligibility and authorization review.
Yes, from 24 online programs that publish a service area including Indiana.
At intake, confirm your address, the exact medication and any pharmacy limits, because a state listing does not guarantee you a prescription or a delivery date.
Among programs that serve Indiana, the lowest complete monthly price we found is $69 at Embody.
Across the 11 compounded programs we track nationally, the median advertised recurring price is $149/mo, from $69 to $299. That national figure is not a measured Indiana average, insurance copay or quote for your dose.
Affiliate partners we feature. We may earn a commission.
Check the medication, commitment and total price for your selected plan.
Affiliate links, we earn a commission at no extra cost to you. These are featured partners, prioritized by our affiliate economics, not an editorial "best" ranking. Published scores have different evidence limits and do not establish better care. See the program comparison and scoring limitations.